Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dicker

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|July 1, 2004
Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cellsSeok-Hyun Kim, Kunhong Kim, Jae G Kwagh, et al.
Elife|July 29, 2021
A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53Liz Hernandez Borrero, David T Dicker, John Santiago, et al.
Cancer Research|November 20, 2013
Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53Bo Hong, Varun V Prabhu, Shengliang Zhang, et al.
Cancer Biology & Therapy|August 26, 2006
Differentiation of normal skin and melanoma using high resolution hyperspectral imagingDavid T Dicker, Jeremy Lerner, Pat Van Belle, et al.
Plos One|October 3, 2013
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axisJunaid Abdulghani, Joshua E Allen, David T Dicker, et al.
Cancer Biology & Therapy|December 2, 2005
Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosisPaul G Corn, M Stacey Ricci, Kimberly A Scata, et al.
Cancer Research|March 12, 2014
COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulationJoshua E Allen, Akshal S Patel, Varun V Prabhu, et al.
Oncotarget|October 12, 2011
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastasesAkshal S Patel, Joshua E Allen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|January 8, 2010
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditionsElizabeth M Matthew, Lori S Hart, Aristotelis Astrinidis, et al.
Science Signaling|February 18, 2016
ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinasesC Leah B Kline, A Pieter J Van den Heuvel, Joshua E Allen, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|July 1, 2004
Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cellsSeok-Hyun Kim, Kunhong Kim, Jae G Kwagh, et al.
Elife|July 29, 2021
A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53Liz Hernandez Borrero, David T Dicker, John Santiago, et al.
Cancer Research|November 20, 2013
Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53Bo Hong, Varun V Prabhu, Shengliang Zhang, et al.
Cancer Biology & Therapy|August 26, 2006
Differentiation of normal skin and melanoma using high resolution hyperspectral imagingDavid T Dicker, Jeremy Lerner, Pat Van Belle, et al.
Plos One|October 3, 2013
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axisJunaid Abdulghani, Joshua E Allen, David T Dicker, et al.
Cancer Biology & Therapy|December 2, 2005
Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosisPaul G Corn, M Stacey Ricci, Kimberly A Scata, et al.
Cancer Research|March 12, 2014
COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulationJoshua E Allen, Akshal S Patel, Varun V Prabhu, et al.
Oncotarget|October 12, 2011
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastasesAkshal S Patel, Joshua E Allen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|January 8, 2010
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditionsElizabeth M Matthew, Lori S Hart, Aristotelis Astrinidis, et al.
Science Signaling|February 18, 2016
ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinasesC Leah B Kline, A Pieter J Van den Heuvel, Joshua E Allen, et al.
Pageof 10